Company Filing History:
Years Active: 2021
Title: Shinsuke Ishigaki: Innovator in Antisense Oligonucleotide Technology
Introduction
Shinsuke Ishigaki is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides. His work focuses on controlling the expression of TDP-43, a protein associated with various neurodegenerative diseases.
Latest Patents
Ishigaki holds a patent for an antisense oligonucleotide that targets TDP-43 mRNA. This invention provides a suppression-type antisense oligonucleotide containing a nucleotide sequence complementary to a sequence of at least 10 continuous nucleotides in specific nucleotide sequences. Additionally, it includes a promotion-type antisense oligonucleotide targeting TDP-43 mRNA, which also contains a complementary nucleotide sequence.
Career Highlights
Throughout his career, Shinsuke Ishigaki has worked with prestigious institutions such as Osaka University and Knc Laboratories Co., Ltd. His research has contributed to advancements in understanding the role of TDP-43 in cellular processes and its implications in disease.
Collaborations
Ishigaki has collaborated with notable colleagues, including Yoshitaka Nagai and Kazuhiro Maeta. These partnerships have enhanced his research and expanded the impact of his inventions.
Conclusion
Shinsuke Ishigaki's innovative work in antisense oligonucleotide technology represents a significant advancement in molecular biology. His contributions continue to influence research in neurodegenerative diseases and therapeutic development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.